Eva Ciruelos, MD, PhD

Eva Ciruelos, MD, PhD, has been a prominent Medical Oncologist in the Breast Cancer Unit at Hospital 12 de Octubre, Madrid, Spain, since January 1997. Beyond her clinical duties, she leads the Breast Cancer Unit at HM Hospitales, Madrid, Spain, a role she has held since January 2018. She also serves as the chair of the SOLTI Group on Breast Cancer Research and works as an Associate Professor at Universidad Complutense, Madrid, Spain. Her academic background includes a PhD from Complutense University and an MSc in Molecular Oncology from the Spanish National Cancer Research Center, Madrid, Spain.

Speaking on clinical research in breast cancer
Dr Ciruelos has made significant contributions to clinical research, particularly in the field of breast cancer treatment. She has played a key role in the PATRICIA Trial, which examines the use of a combination of palbociclib, trastuzumab, and endocrine therapy to improve outcomes for breast cancer patients. Her research also includes a meta-analysis focused on assessing the short-term risk of recurrence in patients with hormone receptor-positive (HER+), HER2-negative (HER2-) receiving endocrine therapy. This work aimed at optimizing treatment strategies and enhancing the ability to predict recurrence, ultimately improving patient care.